OmniAb, Inc.
Status: Publicly traded
Direct answer
OmniAb, Inc. is publicly traded on NASDAQ under the ticker OABI.
OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary...
Can you invest in OmniAb, Inc.?
Yes. OmniAb, Inc. is publicly traded on NASDAQ under the ticker OABI.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for OmniAb, Inc.
Detailed equity research is provided by MarketSnap.